Thermo Fisher Scientific (NYSE: TMO) reported Q1 EPS of $7.25, $1.07 better than the analyst estimate of $6.18. Revenue for the quarter came in at $11.82 billion versus the consensus estimate of $10.63 billion.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.